Raymond R. Tubbs
Department of Molecular Pathology
Cleveland Clinic
Cleveland
OH 44195
USA
Name/email consistency: high
- Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. Tubbs, R., Barlow, W.E., Budd, G.T., Swain, E., Porter, P., Gown, A., Yeh, I.T., Sledge, G., Shapiro, C., Ingle, J., Haskell, C., Albain, K.S., Livingston, R., Hayes, D.F. J. Clin. Oncol. (2009)
- The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts. Tubbs, R.R., Pettay, J., Barry, T.S., Swain, E., Loftus, M., Cook, J.R., Skacel, M., Paine, G., Roche, P., Grogan, T. J. Mol. Histol. (2007)
- Genotyping of phenotypically defined cells in neoplasia: enhanced immunoFISH via tyramide signal amplification (TSA) segregates immunophenotypically-defined cell populations for gated genotyping. Tubbs, R.R., Das, K., Cook, J.R., Pettay, J.D., Roche, P.C., Grogan, T. J. Mol. Histol. (2007)
- An approach to the validation of novel molecular markers of breast cancer via TMA-based FISH scanning. Tubbs, R.R., Swain, E., Pettay, J.D., Hicks, D.G. J. Mol. Histol. (2007)
- Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experience. Tubbs, R.R., Hicks, D.G., Cook, J., Downs-Kelly, E., Pettay, J., Hartke, M.B., Hood, L., Neelon, R., Myles, J., Budd, G.T., Moore, H.C., Andresen, S., Crowe, J.P. Diagn. Mol. Pathol. (2007)
- Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: A feasibility study. Tubbs, R.R., Pettay, J.D., Swain, E., Roche, P.C., Powell, W., Hicks, D.G., Grogan, T. Appl. Immunohistochem. Mol. Morphol. (2006)
- High-resolution immunophenotyping of subcellular compartments in tissue microarrays by enzyme metallography. Tubbs, R., Pettay, J., Powell, R., Hicks, D.G., Roche, P., Powell, W., Grogan, T., Hainfeld, J.F. Appl. Immunohistochem. Mol. Morphol. (2005)
- Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification. Tubbs, R., Pettay, J., Skacel, M., Powell, R., Stoler, M., Roche, P., Hainfeld, J. Am. J. Pathol. (2002)
- Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma. Tubbs, R., Skacel, M., Pettay, J., Powell, R., Myles, J., Hicks, D., Sreenan, J., Roche, P., Stoler, M.H., Hainfeld, J. Am. J. Surg. Pathol. (2002)
- Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. Tubbs, R.R., Pettay, J.D., Roche, P.C., Stoler, M.H., Jenkins, R.B., Grogan, T.M. J. Clin. Oncol. (2001)
- Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression. Tubbs, R.R., Pettay, J., Roche, P., Stoler, M.H., Jenkins, R., Myles, J., Grogan, T. J. Mol. Diagn (2000)
